Financhill
Sell
21

OCX Quote, Financials, Valuation and Earnings

Last price:
$2.23
Seasonality move :
11.63%
Day range:
$2.15 - $2.27
52-week range:
$1.98 - $3.82
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
33.60x
P/B ratio:
3.83x
Volume:
78.2K
Avg. volume:
117.6K
1-year change:
-21.35%
Market cap:
$37.2M
Revenue:
$1.5M
EPS (TTM):
-$4.54
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- $1.2M $2.2M $958K $1.5M
Revenue Growth (YoY) -- -- 80.76% -56.42% 56.89%
 
Cost of Revenues -- $1.9M $778K $976K $1.1M
Gross Profit -- -$639K $1.4M -$18K $413K
Gross Profit Margin -- -52.55% 64.6% -1.88% 27.48%
 
R&D Expenses $6.8M $9.8M $5M $7.3M $9.3M
Selling, General & Admin $15.4M $23.3M $20.4M $21.5M $13.5M
Other Inc / (Exp) -$486K $2.8M -$28.7M $10.3M -$2.4M
Operating Expenses $22.2M $33.1M $25.4M $28.8M $22.8M
Operating Income -$22.2M -$33.7M -$24M -$28.9M -$22.4M
 
Net Interest Expenses -- $252K $209K $83K $52K
EBT. Incl. Unusual Items -$22.4M -$31.2M -$52.9M -$18.6M -$24.9M
Earnings of Discontinued Ops. -- -- -$20.5M -$54.3M -$2.9M
Income Tax Expense -- -$1.3M -$9.3M -- --
Net Income to Company -$22.4M -$29.9M -$64.1M -$72.9M -$27.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$22.4M -$29.9M -$64.1M -$72.9M -$27.8M
 
Basic EPS (Cont. Ops) -$8.80 -$9.20 -$14.40 -$13.25 -$3.75
Diluted EPS (Cont. Ops) -$8.80 -$9.20 -$14.40 -$13.25 -$3.75
Weighted Average Basic Share $2.6M $3.3M $4.4M $5.5M $7.7M
Weighted Average Diluted Share $2.6M $3.3M $4.4M $5.5M $7.7M
 
EBITDA -$21.9M -$30.5M -$48.5M -$13.3M -$23.1M
EBIT -$22.2M -$30.9M -$52.7M -$18.5M -$24.8M
 
Revenue (Reported) -- $1.2M $2.2M $958K $1.5M
Operating Income (Reported) -$22.2M -$33.7M -$24M -$28.9M -$22.4M
Operating Income (Adjusted) -$22.2M -$30.9M -$52.7M -$18.5M -$24.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $555K $984K $67K $429K $115K
Revenue Growth (YoY) -- 77.3% -93.19% 540.3% -73.19%
 
Cost of Revenues $601K $1.9M $336K $181K $65K
Gross Profit -$46K -$866K -$269K $248K $50K
Gross Profit Margin -8.29% -88.01% -401.49% 57.81% 43.48%
 
R&D Expenses $2.6M $3.1M $1.5M $2.2M $2.8M
Selling, General & Admin $6.6M $8.4M $5.5M $3.2M $3.6M
Other Inc / (Exp) $2.5M -$1.3M $5.5M -$1.4M -$7.1M
Operating Expenses $9.2M $11.6M $7M $5.4M $6.4M
Operating Income -$9.2M -$12.4M -$7.3M -$5.1M -$6.4M
 
Net Interest Expenses $78K $50K $14K $14K $31K
EBT. Incl. Unusual Items -$6.8M -$13.8M -$1.8M -$6.5M -$13.5M
Earnings of Discontinued Ops. -- -- -$7.5M -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$6.8M -$13.8M -$9.3M -$6.5M -$13.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$6.8M -$13.8M -$9.3M -$6.5M -$13.5M
 
Basic EPS (Cont. Ops) -$2.00 -$3.00 -$1.62 -$0.81 -$0.98
Diluted EPS (Cont. Ops) -$2.00 -$3.00 -$1.62 -$0.81 -$0.98
Weighted Average Basic Share $3.4M $4.6M $5.9M $8.3M $13.7M
Weighted Average Diluted Share $3.4M $4.6M $5.9M $8.3M $13.7M
 
EBITDA -$5.6M -$12.5M -$5.9M -$6M -$13.1M
EBIT -$6.7M -$13.8M -$7.3M -$6.5M -$13.5M
 
Revenue (Reported) $555K $984K $67K $429K $115K
Operating Income (Reported) -$9.2M -$12.4M -$7.3M -$5.1M -$6.4M
Operating Income (Adjusted) -$6.7M -$13.8M -$7.3M -$6.5M -$13.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $4.6M -$1.3M $1.5M $709K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $6M -$3.9M $960K $824K
Gross Profit -$425K -$1.4M $2.6M $503K -$115K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $10.3M $10.8M $1.9M $8.1M $10M
Selling, General & Admin $23.2M $29M $13.7M $15.8M $12.8M
Other Inc / (Exp) $1.4M -$2.5M -$8.8M $2.6M -$20.2M
Operating Expenses $33.5M $39.9M $15.6M $23.9M $22.8M
Operating Income -$33.9M -$41.2M -$13M -$23.4M -$22.9M
 
Net Interest Expenses $175K $244K $107K $57K $67K
EBT. Incl. Unusual Items -$32.7M -$44M -$21.9M -$20.9M -$43.1M
Earnings of Discontinued Ops. -- -- -$21.3M -$35.9M --
Income Tax Expense -$1.1M -$9.5M -- -- --
Net Income to Company -$31.6M -$34.5M -$63.8M -$56.8M -$43.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$31.6M -$34.5M -$63.8M -$56.8M -$43.1M
 
Basic EPS (Cont. Ops) -$10.40 -$8.20 -$13.10 -$9.51 -$4.54
Diluted EPS (Cont. Ops) -$10.40 -$8.20 -$13.10 -$9.51 -$4.54
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$30.4M -$40.8M -$28.6M -$1.9M -$41.8M
EBIT -$32.1M -$43.8M -$33.8M -$4.5M -$43.1M
 
Revenue (Reported) -- $4.6M -$1.3M $1.5M $709K
Operating Income (Reported) -$33.9M -$41.2M -$13M -$23.4M -$22.9M
Operating Income (Adjusted) -$32.1M -$43.8M -$33.8M -$4.5M -$43.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $714K $4.1M $684K $1.2M $395K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.1M $5.3M $675K $659K $393K
Gross Profit -$425K -$1.2M $9K $530K $2K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $8M $9M $5.9M $6.7M $7.4M
Selling, General & Admin $18M $23.7M $16.9M $11.1M $10.4M
Other Inc / (Exp) $1.9M -$3.5M $16.3M $8.5M -$9.3M
Operating Expenses $26M $32.8M $22.8M $17.9M $17.8M
Operating Income -$26.4M -$33.9M -$22.8M -$17.4M -$17.8M
 
Net Interest Expenses $175K $167K $65K $39K $54K
EBT. Incl. Unusual Items -$24.7M -$37.6M -$6.6M -$8.9M -$27.2M
Earnings of Discontinued Ops. -- -- -$21.3M -$2.9M --
Income Tax Expense -$1.1M -$9.4M -- -- --
Net Income to Company -$23.6M -$28.2M -$27.9M -$11.8M -$27.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$23.6M -$28.2M -$27.9M -$11.8M -$27.2M
 
Basic EPS (Cont. Ops) -$7.40 -$6.40 -$5.30 -$1.48 -$2.47
Diluted EPS (Cont. Ops) -$7.40 -$6.40 -$5.30 -$1.48 -$2.47
Weighted Average Basic Share $9.7M $13.2M $16.2M $22.3M $34.8M
Weighted Average Diluted Share $9.7M $13.2M $16.2M $22.3M $34.8M
 
EBITDA -$23M -$34.5M -$14.6M -$7.5M -$26.1M
EBIT -$24.5M -$37.4M -$18.5M -$8.8M -$27.1M
 
Revenue (Reported) $714K $4.1M $684K $1.2M $395K
Operating Income (Reported) -$26.4M -$33.9M -$22.8M -$17.4M -$17.8M
Operating Income (Adjusted) -$24.5M -$37.4M -$18.5M -$8.8M -$27.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $22.1M $7.1M $32.9M $20M $9.4M
Short Term Investments $379K $675K $904K $433K --
Accounts Receivable, Net -- $203K $1.4M $2M $484K
Inventory -- -- -- -- --
Prepaid Expenses $469K $910K -- -- --
Other Current Assets $36K $295K $901K $977K $643K
Total Current Assets $23M $9.2M $39.1M $25.5M $10.7M
 
Property Plant And Equipment $3.7M $6.5M $8.4M $10.9M $5.4M
Long-Term Investments $11M $13.4M -- -- --
Goodwill -- $9.2M $18.7M -- --
Other Intangibles -- $15M $61.7M $61.6M $56.6M
Other Long-Term Assets $1.9M $2.1M $31.6M $2.1M $2.2M
Total Assets $39.9M $55.4M $159.6M $100.1M $74.9M
 
Accounts Payable $469K $432K $1.8M $1.3M $953K
Accrued Expenses $1.3M $2.3M $3.5M $3.9M $1.6M
Current Portion Of Long-Term Debt $1.1M $2.4M -- -- --
Current Portion Of Capital Lease Obligations $230K $422K $819K $815K $665K
Other Current Liabilities -- -- $1.5M $2M $45K
Total Current Liabilities $4.4M $9M $14.1M $12.1M $7.2M
 
Long-Term Debt $1.9M $1.5M -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $9M $21.9M $94.3M $65.8M $54.4M
 
Common Stock $124.6M $157.2M $253M $294.9M $310.3M
Other Common Equity Adj -- -- $37K $39K $49K
Common Equity $30.8M $33.5M $65.2M $34.3M $20.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $30.8M $33.5M $65.2M $34.3M $20.5M
 
Total Liabilities and Equity $39.9M $55.4M $159.6M $100.1M $74.9M
Cash and Short Terms $22.5M $7.8M $33.9M $20.4M $9.4M
Total Debt -- $3.9M $1.3M -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $10.3M $43.3M $32.1M $13.8M $3.4M
Short Term Investments $361K $923K $419K $441K --
Accounts Receivable, Net $366K $1M $2M $1.9M $209K
Inventory -- -- -- -- $232K
Prepaid Expenses $899K -- -- -- --
Other Current Assets $54K $2.3M $2.2M $672K $627K
Total Current Assets $12M $47.6M $36.6M $16.9M $4.8M
 
Property Plant And Equipment $5.7M $7.6M $11.6M $5.8M $6.5M
Long-Term Investments $13.9M -- -- -- --
Goodwill $9.2M $18.4M $18.7M -- --
Other Intangibles $15M $92.7M $88.4M $56.6M $56.5M
Other Long-Term Assets $1.9M $2M $2.1M $2.2M $2.4M
Total Assets $57.8M $168.3M $157.3M $81.6M $70.2M
 
Accounts Payable $1.3M $1.2M $1.8M $1.1M $872K
Accrued Expenses $792K $4.1M $3.9M $2.1M $2.1M
Current Portion Of Long-Term Debt $2.1M $1.5M -- -- --
Current Portion Of Capital Lease Obligations $456K $786K $827K $720K $1.3M
Other Current Liabilities $600K -- -- $90K $614K
Total Current Liabilities $8.9M $13.4M $13M $8M $9.1M
 
Long-Term Debt $2.1M $178K -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $23.1M $69M $80.5M $44M $60.5M
 
Common Stock $152M $251.2M $292.5M $310M $326.7M
Other Common Equity Adj -- -- $19K $32K $57K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $34.6M $99.3M $76.9M $37.6M $9.7M
 
Total Liabilities and Equity $57.8M $168.3M $157.3M $81.6M $70.2M
Cash and Short Terms $10.7M $44.3M $32.5M $14.2M $3.4M
Total Debt $4.1M $1.7M -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$22.4M -$29.9M -$64.1M -$72.9M -$27.8M
Depreciation & Amoritzation $351K $394K $4.2M $5.2M $1.7M
Stock-Based Compensation $3M $5.1M $6.8M $10M $2.9M
Change in Accounts Receivable -- -$182K -$1.2M -$575K $109K
Change in Inventories -- -- -- -- --
Cash From Operations -$19.7M -$26M -$35.9M -$45.6M -$23.3M
 
Capital Expenditures -- $1.2M $2.2M $4.3M $281K
Cash Acquisitions -$11.2M -$10.5M -$11.7M -- --
Cash From Investing -$12.4M -$11.7M -$14M -$4.3M -$932K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $3M $1.1M -- -- --
Long-Term Debt Repaid -$1.6M -$446K -$1.5M -$1.4M -$117K
Repurchase of Common Stock -- -$14K -$239K -- -$1.1M
Other Financing Activities -$3.3M -$132K -$3.1M -$483K -$427K
Cash From Financing $47.9M $22.8M $78.4M $35.8M $12.2M
 
Beginning Cash (CF) $8M $23.8M $8.8M $37.3M $23.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $15.7M -$14.9M $28.5M -$14.1M -$12.1M
Ending Cash (CF) $23.8M $8.8M $37.3M $23.2M $11.1M
 
Levered Free Cash Flow -$20.6M -$27.2M -$38.2M -$49.9M -$23.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$6.8M -$13.8M -$9.3M -$6.5M -$13.5M
Depreciation & Amoritzation $1.1M $1.2M $1.4M $426K $340K
Stock-Based Compensation $1.8M $1.9M $3.2M $716K $464K
Change in Accounts Receivable -$287K -$7K -$188K -$166K -$124K
Change in Inventories -- -- -- -- -$232K
Cash From Operations -$6M -$11M -$11.4M -$3.8M -$5.6M
 
Capital Expenditures $526K $394K $859K $17K $87K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$526K -$394K -$859K $214K -$87K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$18K -$418K -$528K -$30K -$86K
Repurchase of Common Stock -- -$202K -- -- --
Other Financing Activities -$27K -$187K -- -- -$187K
Cash From Financing $28K $8.2M -$528K -$30K -$255K
 
Beginning Cash (CF) $18.5M $48.2M $46.5M $19.1M $11M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$6.5M -$3.2M -$12.8M -$3.6M -$5.9M
Ending Cash (CF) $12M $45M $33.8M $15.5M $5.1M
 
Levered Free Cash Flow -$6.5M -$11.4M -$12.3M -$3.8M -$5.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$31.6M -$34.5M -$63.8M -$56.8M -$43.1M
Depreciation & Amoritzation $1.6M $1.8M $5.2M $2.6M $1.3M
Stock-Based Compensation $4.9M $6.1M $9.1M $5M $1.9M
Change in Accounts Receivable -$372K -$634K -$958K $108K $254K
Change in Inventories -- -- -- -- --
Cash From Operations -$25.1M -$35M -$43M -$28.5M -$19.8M
 
Capital Expenditures $1.1M $2M $3.9M $819K $566K
Cash Acquisitions -$10.2M -$12M -- -- --
Cash From Investing -$12.5M -$14.1M -$3.9M -$1.8M -$199K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$892K -$1.5M -$1.6M -$187K -$149K
Repurchase of Common Stock -$14K -- -- -- --
Other Financing Activities -$94K -$3.1M -$482K -- --
Cash From Financing $30.2M $82.1M $35.6M $12.1M $9.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$7.5M $33M -$11.3M -$18.3M -$10.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$27.1M -$37M -$46.9M -$29.4M -$20.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$23.6M -$28.2M -$27.9M -$11.8M -$27.2M
Depreciation & Amoritzation $1.5M $3M $3.9M $1.4M $1M
Stock-Based Compensation $4.1M $5.1M $7.4M $2.4M $1.4M
Change in Accounts Receivable -$372K -$824K -$553K $130K $275K
Change in Inventories -- -- -- -- -$232K
Cash From Operations -$19.8M -$28.9M -$35.9M -$18.9M -$15.4M
 
Capital Expenditures $1.1M $1.8M $3.5M $17K $302K
Cash Acquisitions -$10.2M -$11.7M -- -- --
Cash From Investing -$11.3M -$13.6M -$3.5M -$1M -$302K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.1M -- -- -- --
Long-Term Debt Repaid -$178K -$1.3M -$1.3M -$87K -$119K
Repurchase of Common Stock -$14K -$239K -- -$1.1M -$5.4M
Other Financing Activities -$58K -$3.1M -$483K -$427K -$725K
Cash From Financing $19.3M $78.6M $35.9M $12.2M $9.6M
 
Beginning Cash (CF) $60.5M $117.7M $105.9M $55.8M $29.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$11.8M $36.2M -$3.6M -$7.7M -$6.1M
Ending Cash (CF) $48.8M $153.8M $102.4M $48.1M $23.3M
 
Levered Free Cash Flow -$20.9M -$30.7M -$39.5M -$18.9M -$15.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock